Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model

JOURNAL ARTICLE published April 2021 in Anticancer Research

Authors: YUSUKE AOKI | YASUNORI TOME | NATHANIEL F. WU | JUN YAMAMOTO | KAZUYUKI HAMADA | QINGHONG HAN | MICHAEL BOUVET | KOTARO NISHIDA | ROBERT M. HOFFMAN